Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Session: Updates in Treating Bacterial Infections

338 - Asymptomatic Bacteriuria Not a Predictor of Clinical Failure in Uncomplicated Urinary Tract Infections (uUTI): A Prospective Analysis of Women Treated for uUTI from the REASSURE Trial

Friday, October 18, 2024
12:35 PM – 12:40 PM US PT
Location: Halls JK - Arena 4

    Rapid Fire Presenter(s)

  • Steven I. Aronin, MD

    Senior Vice President and Head of Clinical Development
    Iterum Therapeutics
    Old Saybrook, CT, United States

    • Co-Author(s)

  • MD

    Michael Dunne, MD

    Consultant
    Bill & Melinda Gates Medical Research Institute
    Old Saybrook, Connecticut, United States

  • Sailaja Puttagunta, MD

    Chief Medical Officer
    Iterum Therapeutics
    Old Saybrook, Connecticut, United States

Disclosure(s):
Steven I. Aronin, MD: Iterum Therapeutics: Employee, Employee, Stocks/Bonds (Public Company), Stocks/Bonds (Public Company)
Michael Dunne, MD: Iterum Therapeutics: Advisor/Consultant, Board Member, Stocks/Bonds (Public Company)
Sailaja Puttagunta, MD: Iterum Therapeutics: Employee, Employee, Stocks/Bonds (Public Company), Stocks/Bonds (Public Company)